The FDA's clear direction is to advance alternate therapy for cancer pass the long overdue Chemotherapy, that's why BP have been investing heavily in these treatment. Insane buying opportunity for CVI right now given they valued IMU at a low valuation of 1.9c and high of 5c and IMU has released further positive clinical trial update for Azer-Cel and FPI for Ph2 clinical trial for PD1-Vaxx has started since then.
IMU Price at posting:
1.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)